bannerHON
img
HONnews
HONnews
img PATIENT / PARTICULIER img PROFESSIONNEL DE SANTE img WEBMESTRE img
img
 
img
HONcode sites
Khresmoi - new !
HONselect
News
Conferences
Images

Themes:
A B C D E F G H I
J K L M N O P Q
R S T U V W X Y Z
Browse archive:
2017: O S A J J M A M F J
2016: D N O

 
  Other news for:
Substance-Related Disorders
Substance-Related Disorders
 Resources from HONselect
Heroin Vaccine Blocks Drug High in Tests on Monkeys
Researchers hope it will prove as effective in human tests and become an aid for recovering addicts

By Robert Preidt

WEDNESDAY, June 7, 2017 (HealthDay News) -- A vaccine designed to block a heroin "high" worked in monkeys, which could open the door to human clinical trials, researchers say.

This is the first vaccine against an opioid proved to be effective at this stage of testing, according to the development team at The Scripps Research Institute in La Jolla, Calif.

The vaccine already worked in rodents.

For the new trial, four rhesus monkeys given three doses of the vaccine had an effective immune response that neutralized varying doses of heroin. The effect was strongest in the first month but lasted more than eight months after vaccination. It caused no adverse side effects, according to the researchers.

The study was published June 2 in the Journal of the American Chemical Society.

"We believe this vaccine candidate will prove safe for human trials," study leader Kim Janda said in a Scripps news release. Janda is a professor of chemistry at the institute.

Components of the vaccine already have FDA approval or have passed safety tests in previous clinical trials, Janda said.

The vaccine trains the immune system to produce antibodies that neutralize heroin molecules, preventing them from reaching the brain to cause a high.

The vaccine doesn't work against other opioid painkillers or medicines used to treat opioid addiction or overdose, the researchers said.

Blocking heroin's high could help keep many recovering addicts from relapsing into drug use, the researchers added.

The next step is finding a corporate partner for human clinical trials.

More information

The U.S. National Institute on Drug Abuse has more about heroin.

SOURCE: The Scripps Research Institute, news release, June 6, 2017

Copyright © 2017 HealthDay. All rights reserved. URL:http://consumer.healthday.com/Article.asp?AID=723451

Resources from HONselect: HONselect is the HON's medical search engine. It retrieves scientific articles, images, conferences and web sites on the selected subject.
Research Personnel
Substance-Related Disorders
Brain
The list of medical terms above are retrieved automatically from the article.

Disclaimer: The text presented on this page is not a substitute for professional medical advice. It is for your information only and may not represent your true individual medical situation. Do not hesitate to consult your healthcare provider if you have any questions or concerns. Do not use this information to diagnose or treat a health problem or disease without consulting a qualified healthcare professional.
Be advised that HealthDay articles are derived from various sources and may not reflect your own country regulations. The Health On the Net Foundation does not endorse opinions, products, or services that may appear in HealthDay articles.


Home img About us img MediaCorner img HON newsletter img Site map img Ethical policies img Contact